Marpai, Inc. (NASDAQ:MRAI – Get Rating) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totalling 50,200 shares, a drop of 26.3% from the November 30th total of 68,100 shares. Approximately 0.5% of the company's shares are short sold. Based on an average trading volume of 20,800 shares, the short-interest ratio is presently 2.4 days.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Marpai stock. Vanguard Group Inc. boosted its stake in shares of Marpai, Inc. (NASDAQ:MRAI – Get Rating) by 63.0% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 363,332 shares of the company's stock after purchasing an additional 140,407 shares during the period. Vanguard Group Inc. owned about 1.79% of Marpai worth $654,000 at the end of the most recent reporting period. 35.90% of the stock is owned by hedge funds and other institutional investors.
Get
Marpai alerts:
Marpai Price Performance
Marpai stock opened at $0.72 on Monday. The firm's 50 day simple moving average is $0.92 and its 200-day simple moving average is $0.95. The company has a market cap of $15.08 million, a P/E ratio of -0.58 and a beta of 0.40. Marpai has a fifty-two week low of $0.69 and a fifty-two week high of $4.57.
Marpai (NASDAQ:MRAI – Get Rating) last released its earnings results on Wednesday, November 9th. The company reported ($0.28) earnings per share for the quarter. The firm had revenue of $4.94 million during the quarter. Marpai had a negative return on equity of 108.51% and a negative net
margin of 104.66%.
About Marpai
(Get Rating)
Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services.
Further Reading
- Get a free copy of the StockNews.com research report on Marpai (MRAI)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
Receive News & Ratings for Marpai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marpai and related companies with MarketBeat.com's FREE daily email newsletter.
